In December of 2021, the DEA quickly put several nitazenes on its Program I [9]. Since there are number of validated strategies to find these substances and minimal is thought in regards to the community of clandestine labs and chemists who manufacture these medicines, the geographical distribution of those medications is just not known [7]."Entry